Publications by Anders Glomstein
55 publications found
Original articles
RALLE pilot: response-guided therapy for marrow relapse in acute lymphoblastic leukemia in children
J Pediatr Hematol Oncol, 34 (4), 263-70
DOI 10.1097/MPH.0b013e3182352da9, PubMed 22246158
Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients
Bone Marrow Transplant, 47 (3), 352-9
DOI 10.1038/bmt.2011.99, PubMed 21552297
Home treatment with bypassing products in inhibitor patients: a 7.5-year experience
Haemophilia, 15 (3), 727-32
DOI 10.1111/j.1365-2516.2009.02017.x, PubMed 19320748
Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions
Haematologica, 93 (7), 1076-80
DOI 10.3324/haematol.12594, PubMed 18492691
[Childhood acute lymphoblastic leukemia in Norway 1992-2000]
Tidsskr Nor Laegeforen, 127 (11), 1493-5
PubMed 17551551
Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data
J Clin Oncol, 24 (36), 5750-62
DOI 10.1200/JCO.2006.07.1225, PubMed 17179109
Acute leukaemia in children with Down syndrome: a population-based Nordic study
Br J Haematol, 128 (6), 797-804
DOI 10.1111/j.1365-2141.2005.05398.x, PubMed 15755283
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden
Haemophilia, 10 (5), 515-26
DOI 10.1111/j.1365-2516.2004.00952.x, PubMed 15357779
Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation
Pediatr Blood Cancer, 42 (1), 8-23
DOI 10.1002/pbc.10461, PubMed 14752789
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome
Haemophilia, 9 (5), 555-66
DOI 10.1046/j.1365-2516.2003.00817.x, PubMed 14511294
Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia
J Clin Oncol, 21 (7), 1332-9
DOI 10.1200/JCO.2003.04.039, PubMed 12663723
Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience
Pediatr Hematol Oncol, 20 (3), 187-200
DOI 10.1080/08880010390158810, PubMed 12637215
No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission
J Clin Oncol, 19 (14), 3406-14
DOI 10.1200/JCO.2001.19.14.3406, PubMed 11454889
Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO)
Leukemia, 14 (12), 2267-75
DOI 10.1038/sj.leu.2401961, PubMed 11187918
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries
Haemophilia, 6 (6), 619-24
DOI 10.1046/j.1365-2516.2000.00427.x, PubMed 11122385
[Long-term survival following surgery and radiotherapy of brain tumors in childhood]
Tidsskr Nor Laegeforen, 120 (10), 1142-5
PubMed 10863342
Von Willebrand disease in Norway
Haemophilia, 5 Suppl 2, 70
DOI 10.1046/j.1365-2516.1999.0050s2070.x, PubMed 23401905
Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries
Bone Marrow Transplant, 23 (6), 555-60
DOI 10.1038/sj.bmt.1701617, PubMed 10217185
[Adults treated as children for acute lymphocytic leukemia--methotrexate, late effects and quality of life]
Tidsskr Nor Laegeforen, 119 (4), 499-503
PubMed 10081372
Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity
Am J Hum Genet, 63 (5), 1388-95
DOI 10.1086/302100, PubMed 9792865
Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO)
J Pediatr Hematol Oncol, 19 (2), 102-9
DOI 10.1097/00043426-199703000-00002, PubMed 9149738
[Investigation and treatment of immune thrombocytopenic purpura in children in Norway]
Tidsskr Nor Laegeforen, 116 (18), 2157-9
PubMed 8801655
Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO)
Bone Marrow Transplant, 17 (3), 357-63
PubMed 8704687
Self-sufficiency and blood transmitted diseases
Blood Coagul Fibrinolysis, 6 Suppl 2, S23-6
DOI 10.1097/00001721-199506002-00006, PubMed 7495963
Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology
J Clin Oncol, 13 (2), 345-51
DOI 10.1200/JCO.1995.13.2.345, PubMed 7531219
Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia
Scand J Infect Dis, 24 (3), 391-3
DOI 10.3109/00365549209061349, PubMed 1509246
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
Scand J Infect Dis, 23 (6), 675-9
DOI 10.3109/00365549109024292, PubMed 1815327
[Autologous bone marrow transplantation in children--experience with neuroblastoma]
Tidsskr Nor Laegeforen, 110 (19), 2513-6
PubMed 2219008
Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects
Blut, 60 (2), 93-6
DOI 10.1007/BF01720514, PubMed 2154272
MEDULLOBLASTOMA IN NORDIC CHILDREN .2. NEUROLOGIC AND SOCIAL PROGNOSIS IN LONG-TERM SURVIVORS
ACTA PAEDIATR SCAND (371), 12-19
MEDULLOBLASTOMA IN NORDIC CHILDREN .3. LONG-TERM GROWTH AND ENDOCRINE SEQUELAE
ACTA PAEDIATR SCAND (371), 20-27
MEDULLOBLASTOMA IN NORDIC CHILDREN .1. INCIDENCE AND MORTALITY
ACTA PAEDIATR SCAND (371), 5-11
Feulgen DNA values in Wilms' tumour in relation to prognosis
Pathol Res Pract, 183 (6), 756-60
DOI 10.1016/S0344-0338(88)80061-X, PubMed 2464818
Bone marrow transplantation in metabolic diseases
Transplant Proc, 20 (3), 499-500
PubMed 3132771
The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV-infected hemophiliacs
Eur J Haematol, 39 (4), 353-5
DOI 10.1111/j.1600-0609.1987.tb00782.x, PubMed 3480236
HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors
Eur J Haematol, 39 (1), 44-8
DOI 10.1111/j.1600-0609.1987.tb00162.x, PubMed 3115823
[Tumors in children]
Nord Med, 102 (10), 261-4
PubMed 3697041
[Treatment of hemophiliacs with antibodies to factor VIII]
Tidsskr Nor Laegeforen, 106 (1), 35-8
PubMed 3082032
[Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives]
Tidsskr Nor Laegeforen, 106 (1), 19-21
PubMed 3006278
[Self-sufficiency with factor VIII in Norway. Use of freeze-dried cryoprecipitates instead of purified factor VIII concentrates]
Tidsskr Nor Laegeforen, 106 (1), 16-8
PubMed 3082031
Adult Wilms tumor. A case report
Scand J Urol Nephrol, 19 (4), 305-8
DOI 10.3109/00365598509180277, PubMed 3003890
[Institute for hemophiliacs. Experiences from a 10 years' care of a small group of functionally disabled]
Tidsskr Nor Laegeforen, 101 (32), 1804-7
PubMed 7342360
[Bone marrow transplantation. A review]
Tidsskr Nor Laegeforen, 101 (31), 1755-9
PubMed 7041327
Cellular immune defects to Epstein-Barr virus-determined antigens in young males
Cancer Res, 41 (11 Pt 1), 4284-91
PubMed 6171337
Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease
Cancer Chemother Pharmacol, 2 (1), 61-6
DOI 10.1007/BF00253107, PubMed 291502
The effect of nifedipine on the isolated rat heart
Acta Pharmacol Toxicol (Copenh), 38 (4), 326-35
DOI 10.1111/j.1600-0773.1976.tb03127.x, PubMed 946731
EFFECT OF NIFEDIPINE ON ISOLATED RAT-HEART
ACTA PHARMACOL TOX, 38 (4), 326-335
The effect of thioridazine and promazine on the isolated contracting rat heart
Acta Pharmacol Toxicol (Copenh), 27 (2), 173-82
DOI 10.1111/j.1600-0773.1969.tb00504.x, PubMed 5819571
Effects of adrenaline on coronary flow in isolated perfused rat hearts
Acta Physiol Scand, 69 (1), 102-10
DOI 10.1111/j.1748-1716.1967.tb03495.x, PubMed 6031383
Review articles
Long-term survival and quality of life in patients treated with a national all protocol 15-20 years earlier: IDM/HDM and late effects?
Pediatr Hematol Oncol, 14 (6), 513-24
DOI 10.3109/08880019709030908, PubMed 9383804
Other articles
Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate
Eur J Clin Microbiol Infect Dis, 14 (7), 631-2
DOI 10.1007/BF01690743, PubMed 7588856
[Avoiding the use of not virus-inactivated plasma]
Tidsskr Nor Laegeforen, 112 (18), 2389
PubMed 1412247
[Treatment of von Willebrand's disease with coagulation factor concentrates]
Tidsskr Nor Laegeforen, 111 (15), 1886
PubMed 1853330
Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools
Eur J Clin Microbiol Infect Dis, 9 (8), 612-4
DOI 10.1007/BF01967219, PubMed 2170135
Books
Håndbok for blødere (Hemofili)
[Institutt for blødere], [S.l.], [59] bl.
BIBSYS 010987843